Dr. Gary E. Goodman MD
Hematologist (Blood Specialist) | Hematology
1221 Madison St Seattle WA, 98104About
Dr. Gary Goodman is a hematology internist practicing in Seattle, WA. Dr. Goodman specializes in cases of suspected blood disorders when a diagnosis is unclear and further medical care is needed. Hematology internists work with other specialists such as surgeons, radiation therapists and gynecologists in order to get a better understanding on the cases. Often, patients are asked to participate in clinical research that could result in more efficient treatment methods.
Education and Training
Univ of Il Coll of Med, Chicago Il 1974
University of Illinois College of Medicine 1974
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
- Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET).
- Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
- Prior lung disease and risk of lung cancer in a large prospective study.
- Chlamydia pneumoniae infection and risk of lung cancer.
- Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial.
- Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients.
- Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
- Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
- V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
- Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort.
- A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
- Retinol, vitamins, and cancer prevention: 25 years of learning and relearning.
- Assessing toxicity in cancer chemoprevention trials: the other side of the coin.
- Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers.
Clinical Trials
- Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
- S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
- S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer
- Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
- S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
- S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
- S0820, Adenoma and Second Primary Prevention Trial
- Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
- S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
- Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
- Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
- Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
- Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
- Cabozantinib S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
- Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Treatments
- Melanoma
- Throat Cancer
- Skin Cancer
- Breast Cancer
- Kidney Cancer
- Lung Cancer
- Lymphoma
- Extra Corporeal Shockwave Therapy
Dr. Gary E. Goodman MD's Practice location
Dr. Gary E. Goodman MD's reviews
Write ReviewPatient Experience with Dr. Goodman
Recommended Articles
- What are the Signs and Symptoms of Leukemia?
Although requiring a definite medical diagnosis, leukemia doesn’t show any symptoms in patients suffering from slow growing leukemias. Whereas, the rapidly growing types show general symptoms like frequent infections, vulnerability to easy bleeding & brushes, fatigue and weight loss. The signs...
- Causes, Treatment, and Prevention of Petechiae
Petechiae are tiny dots that appear as red, brown, or purple in color beneath the skin. They are usually seen in clusters on the stomach, buttocks, arms, and legs. However, they may also appear inside the mouth or on the eyelids. Petechiae may indicate different conditions, which can range from...
- How is Multiple Myeloma Diagnosed?
Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...
- Which Doctor Should I see if I have Anemia?
When it comes to health problems, many people become ignorant assuming that every other infection is the common cold, and a little rest and some warm soup will suffice to make problems go away. What they fail to realize is that this ignorance not only leads to unawareness of the disease or disorder...
- Cyclist Battles Back from Lymphoma to Make Professional Debut
In October of 2015, 16-year-old Zack Gilmore felt a lump behind his ear after finishing a cycling training session. He went to the doctor to find out what it was and, three days later, he received the dreadful news: a non-Hodgkin’s lymphoma diagnosis. Gilmore began chemotherapy right away at the...
- Lymphoma GoFundMe Success Stories
When a community or group of friends bands together to help one another, miracles happen. There is nothing more humbling than seeing a community take time of their own to help a friend or community member in need. The more people there are, the bigger difference they can make. There are hundreds of...
Nearby Providers
- Mrs. Danielle Nance MD921 Terry Ave Seattle WA 98104
- Dr. Roland B Walter MD PHD825 Eastlake Ave E Seattle WA 98109
- Dr. Michele B Frank MD12303 Ne 130th Ln Kirkland WA 98034
- Dr. Sioban B Keel MD825 Eastlake Ave E Seattle WA 98109
- Dr. Paul Curtis Hendrie M.D. PH.D.825 Eastlake Ave E Seattle WA 98109
- Dr. Saul E. Rivkin MD1221 Madison St Seattle WA 98104